Nanoparticle albumin-bound paclitaxel for metastatic breast cancer

被引：68
|
作者：
Harries, M [1 ]
Ellis, P [1 ]
Harper, P [1 ]
机构：
[1] Guys & St Thomas Hosp, Dept Med Oncol, London SE1 9RT, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 31期
关键词：
D O I：
10.1200/JCO.2005.08.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7768 / 7771
页数：4
相关论文
共 50 条
  • [31] Antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer
    Zhang, Changhua
    Ostapoff, Katherine T.
    Awasthi, Niranjan
    Schwarz, Margaret A.
    Schwarz, Roderich
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [32] Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer
    G. Roviello
    F. U. Conter
    E. Mini
    D. Generali
    M. Traversini
    D. Lavacchi
    S. Nobili
    N. Sobhani
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 669 - 677
  • [33] Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer
    Roviello, G.
    Conter, F. U.
    Mini, E.
    Generali, D.
    Traversini, M.
    Lavacchi, D.
    Nobili, S.
    Sobhani, N.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 669 - 677
  • [34] Nanoparticle Albumin-Bound Paclitaxel is More Effective Than Paclitaxel in Experimental Endometrial Cancer
    Huang, Jing
    Huo, Hongqi
    Chen, Mulan
    Wang, Lili
    Li, Nani
    Huang, Zhijian
    Yang, Lin
    SCIENCE OF ADVANCED MATERIALS, 2022, 14 (05) : 829 - 835
  • [35] Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer
    Takashima, Tsutomu
    Kawajiri, Hidemi
    Nishimori, Takeo
    Tei, Seika
    Nishimura, Shigehiko
    Yamagata, Shigehito
    Tokunaga, Shinya
    Mizuyama, Yoko
    Sunami, Takeshi
    Tezuka, Kenji
    Ikeda, Katsumi
    Ogawa, Yoshinari
    Kashiwagi, Shinichiro
    Noda, Satoru
    Onoda, Naoyoshi
    Ishikawa, Tetsuro
    Kudoh, Shinzoh
    Takada, Minoru
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2018, 38 (01) : 379 - 383
  • [36] Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients
    Fabi, Alessandra
    Ferretti, Gianluigi
    Malaguti, Paola
    Gasparro, Simona
    Nistico, Cecilia
    Arpino, Grazia
    Papaldo, Paola
    Russillo, Michelangelo
    Catania, Giovanna
    Schettini, Francesco
    Giannarelli, Diana
    Cognetti, Francesco
    FUTURE ONCOLOGY, 2020, 16 (22) : 1629 - 1637
  • [37] Evaluation of neoadjuvant weekly nanoparticle albumin-bound paclitaxel for HER2-negative breast cancer
    Nagayama, A.
    Matsui, A.
    Tachibana, A.
    Suzuki, N.
    Hirata, M.
    Oishi, Y.
    Hamaguchi, Y.
    Murata, Y.
    Okamoto, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis
    Zong, Yu
    Wu, Jiayi
    Shen, Kunwei
    ONCOTARGET, 2017, 8 (10) : 17360 - 17372
  • [39] A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer
    Nanda, Rita
    Stringer-Reasor, Erica M.
    Saha, Poornima
    Kocherginsky, Masha
    Gibson, Jean
    Libao, Bernadette
    Hoffman, Philip C.
    Obeid, Elias
    Merkel, Douglas E.
    Khramtsova, Galina
    Skor, Maxwell
    Krausz, Thomas
    Cohen, Ronald N.
    Ratain, Mark J.
    Fleming, Gini F.
    Conzen, Suzanne D.
    SPRINGERPLUS, 2016, 5
  • [40] A PILOT NEOADJUVANT STUDY OF SEQUENTIAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOLLOWED BY FEC IN ADVANCED BREAST CANCER
    Ohtani, S.
    Kochi, M.
    Abe, K.
    Sakata, Y.
    Hiraki, K.
    Fujiwara, Y.
    Iwamoto, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 127 - 127
12345